The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|April 1, 1999
Supplements and Featured Publications
- Use of Selective Estrogen Receptor Modulators among Postmenopausal Women in the Managed Care Setting
- Volume 5
- Issue 3 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 27 years ago
An Introduction to SERMS and Their Gynecologic Effectsover 27 years ago
Cardiovascular Effects of Selective Estrogen Receptor Modulatorsover 27 years ago
Selective Estrogens and Breast Tissueover 27 years ago
Discussionover 27 years ago
Selected Abstractsover 27 years ago
CME Quizover 27 years ago
Bibliographyover 27 years ago
Skeletal Effects of Selective Estrogen Receptor ModulatorsAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5